| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |